Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Net Cash Flow (2016 - 2025)

Skinvisible's Net Cash Flow history spans 16 years, with the latest figure at $525.0 for Q3 2025.

  • For Q3 2025, Net Cash Flow rose 108.23% year-over-year to $525.0; the TTM value through Sep 2025 reached $4120.0, down 54.72%, while the annual FY2024 figure was $9448.0, 111.74% up from the prior year.
  • Net Cash Flow for Q3 2025 was $525.0 at Skinvisible, up from -$9189.0 in the prior quarter.
  • Across five years, Net Cash Flow topped out at $164543.0 in Q2 2022 and bottomed at -$52240.0 in Q1 2023.
  • The 5-year median for Net Cash Flow is -$4817.0 (2023), against an average of $282.0.
  • The largest annual shift saw Net Cash Flow plummeted 539.86% in 2021 before it skyrocketed 6093.63% in 2024.
  • A 5-year view of Net Cash Flow shows it stood at $16814.0 in 2021, then crashed by 373.79% to -$46035.0 in 2022, then soared by 100.34% to $157.0 in 2023, then surged by 6093.63% to $9724.0 in 2024, then plummeted by 94.6% to $525.0 in 2025.
  • Per Business Quant, the three most recent readings for SKVI's Net Cash Flow are $525.0 (Q3 2025), -$9189.0 (Q2 2025), and $3060.0 (Q1 2025).